J. D. ELLIOTT

667 total citations
16 papers, 519 citations indexed

About

J. D. ELLIOTT is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J. D. ELLIOTT has authored 16 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in J. D. ELLIOTT's work include Nitric Oxide and Endothelin Effects (10 papers), Asymmetric Hydrogenation and Catalysis (2 papers) and Electron Spin Resonance Studies (2 papers). J. D. ELLIOTT is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Asymmetric Hydrogenation and Catalysis (2 papers) and Electron Spin Resonance Studies (2 papers). J. D. ELLIOTT collaborates with scholars based in United States and United Kingdom. J. D. ELLIOTT's co-authors include Eliot H. Ohlstein, P Nambi, Calvert Louden, G. Feuerstein, Lynne M. Vickery‐Clark, Barbara L. Storer, John G. Gleason, David P. Brooks, M. Gellai and R R Ruffolo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J. D. ELLIOTT

16 papers receiving 498 citations

Peers

Countries citing papers authored by J. D. ELLIOTT

Since Specialization

Citations

This map shows the geographic impact of J. D. ELLIOTT's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. D. ELLIOTT with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. D. ELLIOTT more than expected).

Fields of papers citing papers by J. D. ELLIOTT

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. D. ELLIOTT. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. D. ELLIOTT. The network helps show where J. D. ELLIOTT may publish in the future.

Co-authorship network of co-authors of J. D. ELLIOTT

This figure shows the co-authorship network connecting the top 25 collaborators of J. D. ELLIOTT. A scholar is included among the top collaborators of J. D. ELLIOTT based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. D. ELLIOTT. J. D. ELLIOTT is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A one-pot Pd- and P450-catalyzed chemoenzymatic synthesis of a library of oxyfunctionalized biaryl alkanoic acids leveraging a substrate anchoring approach 2023 ·Journal of Inorganic Biochemistry ·(unknown), Michael Huynh, (unknown), J. D. ELLIOTT, (unknown), (unknown), (unknown), Daniel M. Parker, Lionel Cheruzel	1
2	Change in fat soluble vitamin concentrations following the introduction of AquADEK in adults patients with cystic fibrosis 2010 ·Journal of Cystic Fibrosis ·J. D. ELLIOTT, (unknown), Caroline Cox, (unknown), Paul Walker, (unknown), Helen Barker, R. Andrés Floto, (unknown)	2
3	Effect of SB 217242 on Hypoxia-Induced Cardiopulmonary Changes in the High Altitude-Sensitive Rat 1999 ·Pulmonary Pharmacology & Therapeutics ·David C. Underwood, Steven Bochnowicz, Ruth R. Osborn, Mark A. Luttmann, Calvert Louden, (unknown), J. D. ELLIOTT, Douglas W.P. Hay	13
4	Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Eliot H. Ohlstein, P Nambi, Amparo M. Lago, Douglas W.P. Hay, George R. Beck, K L Fong, (unknown), Philip L. Smith, Harma Ellens, J. D. ELLIOTT	46
5	Endothelin receptor subtypes in the pathogenesis of angioplasty-induced neointima formation in the rat: a comparison of selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209670. 1995 ·PubMed ·Stephen A. Douglas, Lynne M. Vickery‐Clark, Calvert Louden, J. D. ELLIOTT, (unknown)	13
6	The Endothelin Receptor Antagonist SB 217242 Reduces Cerebral Focal Ischemic Brain Injury 1995 ·Journal of Cardiovascular Pharmacology ·Frank C. Barone, Ray F. White, J. D. ELLIOTT, G Feuerstein, Eliot H. Ohlstein	47
7	Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·M. Gellai, M Jugus, Tracey Fletcher, P Nambi, Eliot H. Ohlstein, J. D. ELLIOTT, David P. Brooks	61
8	Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·David P. Brooks, (unknown), M. Gellai, P Nambi, Eliot H. Ohlstein, J. D. ELLIOTT, John G. Gleason, R R Ruffolo	37
9	Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Eliot H. Ohlstein, George R. Beck, (unknown), P Nambi, M. Amparo Lago, John G. Gleason, R R Ruffolo, G. Feuerstein, J. D. ELLIOTT	38
10	Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·P Nambi, Nabil A. Elshourbagy, (unknown), M Pullen, Eliot H. Ohlstein, David P. Brooks, M. Amparo Lago, J. D. ELLIOTT, John G. Gleason, R R Ruffolo	27
11	A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. 1994 ·Circulation Research ·(unknown), Calvert Louden, Lynne M. Vickery‐Clark, Barbara L. Storer, (unknown), G. Feuerstein, J. D. ELLIOTT, Eliot H. Ohlstein	161
12	Tyr-129 is important to the peptide ligand affinity and selectivity of human endothelin type A receptor. 1994 ·Proceedings of the National Academy of Sciences ·(unknown), J. D. ELLIOTT, (unknown), Westley J. Friesen, Eliot H. Ohlstein, Jeffrey M. Stadel, John G. Gleason, Catherine E. Peishoff	36
13	Maximize distillate liquid products 1992 ·Hydrocarbon processing ·J. D. ELLIOTT	6
14	Design, operation factors can up coker liquid yields. [Delayed liquid cooling] 1991 ·J. D. ELLIOTT	1
15	Asymmetric Synthesis via Acetal Templates. 14.1 Preparation of Enantiomerically Pure (3S,4S)- and (3S,4R)-Statine Derivatives 1987 ·Tetrahedron Letters ·(unknown), (unknown), J. D. ELLIOTT, William S. Johnson, (unknown)	29
16	Delayed coking: latest trends 1982 ·Hydrocarbon Process ·(unknown), J. D. ELLIOTT	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact